Gunagratinib
Based on 1 publication(s) in Google Scholar
Gunagratinib (ICP-192) is a low toxicity and orally active pan-FGFR (fibroblast growth factor receptors) inhibitor that potently and selectively inhibits FGFR activities irreversibly by covalent binding. Gunagratinib can be used for the research of cancer. Gunagratinib is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 98.52%
- CAS. Nr.: 2211082-53-8
- Formel: C22H25N5O4
- Molecular Weight:423.47
-
Speicherung:
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
-
Lösungsmittel & Löslichkeit
- Protokoll
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
-
HY-13330
FexagratinibFGFR Inhibitor -
HY-100818
FutibatinibFGFR Inhibitor -
HY-109099
PemigatinibFGFR Inhibitor -
HY-19981
Derazantinib -
HY-156632
ResigratinibFGFR Inhibitor -
HY-13311
InfigratinibFGFR Inhibitor -
HY-13304
LY2874455FGFR Inhibitor -
HY-19957
Zoligratinib -
HY-100019
RogaratinibFGFR1-4 Inhibitor -
HY-100492
FisogatinibFGFR4 Inhibitor -
HY-101466
E7090FGFR1/2/3 Inhibitor -
HY-18708
ErdafitinibFGFR Inhibitor
Publications Citing Use of MedChemExpress (MCE) Gunagratinib
More
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
FGFR |
In Vitro
Gunagratinib (ICP-192) is a low toxicity and orally active pan-FGFR (fibroblast growth factor receptors) inhibitor that potently and selectively inhibits FGFR activities irreversibly by covalent binding[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS. Nr. 2211082-53-8
-
Appearance Solid
-
Molecular Weight 423.47
-
Formel C22H25N5O4
-
Color White to off-white
-
SMILES
CNC1=C(C(N)=O)C(C#CC2=CC(OC)=CC(OC)=C2)=NN1[C@]3([H])CN(CC3)C(C=C)=O
-
Synonyms
ICP-192
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Publications (1)
-
Journal Impact Factor
-
Most Recent
Lösungsmittel & Löslichkeit
In Vitro:
DMSO : 100 mg/mL (236.14 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Protokoll
-
EdU Incorporation Assay (Click Chemistry-Based DNA Synthesis Measurement)
The EdU incorporation assay measures DNA synthesis by adding the thymidine analog 5-ethynyl-2′-deoxyuridine to cells or tissues, where it is incorporated into newly synthesized DNA during S phase. Incorporated EdU is detected by copper-catalyzed azide-alkyne cycloaddition, in which a fluorescent azide covalently reacts with the ethynyl group on EdU, allowing S-phase cells to be detected by fluorescence microscopy, flow cytometry, or high-content imaging. EdU detection does not require DNA denaturation or anti-BrdU antibody access, which preserves sample structure and improves compatibility with immunostaining and multiparameter cytometry compared with BrdU-based detection. EdU can be cytotoxic in a cell-type- and exposure-dependent manner, so pulse duration, concentration, and continuous-labeling designs should be validated for each cell type.
Reinheit & Dokumentation
-
Data Sheet (274 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
Verweise
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.3614 mL | 11.8072 mL | 23.6144 mL | 59.0361 mL |
| 5 mM | 0.4723 mL | 2.3614 mL | 4.7229 mL | 11.8072 mL | |
| 10 mM | 0.2361 mL | 1.1807 mL | 2.3614 mL | 5.9036 mL | |
| 15 mM | 0.1574 mL | 0.7871 mL | 1.5743 mL | 3.9357 mL | |
| 20 mM | 0.1181 mL | 0.5904 mL | 1.1807 mL | 2.9518 mL | |
| 25 mM | 0.0945 mL | 0.4723 mL | 0.9446 mL | 2.3614 mL | |
| 30 mM | 0.0787 mL | 0.3936 mL | 0.7871 mL | 1.9679 mL | |
| 40 mM | 0.0590 mL | 0.2952 mL | 0.5904 mL | 1.4759 mL | |
| 50 mM | 0.0472 mL | 0.2361 mL | 0.4723 mL | 1.1807 mL | |
| 60 mM | 0.0394 mL | 0.1968 mL | 0.3936 mL | 0.9839 mL | |
| 80 mM | 0.0295 mL | 0.1476 mL | 0.2952 mL | 0.7380 mL | |
| 100 mM | 0.0236 mL | 0.1181 mL | 0.2361 mL | 0.5904 mL |
Gunagratinib Related Classifications
HY-132817 Related Classifications
Powered by Bioz